The purified compounds were tested on nucleophosmin-mutated acute myeloid leukemia and other hematological cancer cell lines to assess their effects on the cell cycle, cell viability and apoptosis, and the expression of ZNF217. The gene discussed is ZNF217; the disease is hematopoietic and lymphoid cell neoplasm.